Determination of S- and R-warfarin enantiomers by using modified HPLC method.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pakistan Journal of Pharmaceutical Sciences

• Publication date

  2015-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 26142522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International conference on harmonization of technical requirements for registration of pharmaceuticals for human use

  2015cited by this paper
• Development of a chiral micellar electrokinetic chromatography-tandem mass spectrometry assay for simultaneous analysis of warfarin and hydroxywarfarin metabolites: application to the analysis of patients serum samples.

  2013cited by this paper
• The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.

  2012cited by this paper
• On rat poison and human medicines: personalizing warfarin therapy.

  2012cited by this paper
• Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study

  2012cited by this paper
• Influence of CYP2C9 and VKORC1 on Patient Response to Warfarin: A Systematic Review and Meta-Analysis

  2012cited by this paper
• [Enantioselective determinination of R-warfarin/S-warfarin in human plasma using liquid chromatography-tandem mass spectrometry and its application in a drug-drug interaction study].

  2012cited by this paper
• Guidelines on oral anticoagulation with warfarin – fourth edition

  2011cited by this paper
• Coupling of acetonitrile deproteinization and salting-out extraction with acetonitrile stacking in chiral capillary electrophoresis for the determination of warfarin enantiomers.

  2011cited by this paper
• Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.

  2011cited by this paper
• New high-performance liquid chromatography method for the determination of (R)-warfarin and (S)-warfarin using chiral separation on a glycopeptide-based stationary phase.

  2009cited by this paper
• Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues

  2008cited by this paper
• Measurement of free concentrations of highly protein-bound warfarin in plasma by ultra performance liquid chromatography-tandem mass spectrometry and its correlation with the international normalized ratio.

  2008cited by this paper
• Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008influential reference
• CYP2C9 Genotype‐guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

  2008influential reference
• Separation and determination of warfarin enantiomers in human plasma using a novel polymeric surfactant for micellar electrokinetic chromatography-mass spectrometry.

  2007cited by this paper
• Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

  2006cited by this paper
• Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.

  2005cited by this paper
• Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

  2005cited by this paper
• The development and application of a surface plasmon resonance-based inhibition immunoassay for the determination of warfarin in plasma ultrafiltrate.

  2004cited by this paper
• High-performance liquid-chromatographic determination of warfarin enantiomers in plasma with automated on-line sample enrichment.

  2002cited by this paper
• Managing warfarin therapy in the community

  2001cited by this paper
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.

  2001cited by this paper
• Validation of a method for the determination of (R)-warfarin and (S)-warfarin in human plasma using LC with UV detection.

  2000cited by this paper
• Guidance for Industry

  1998cited by this paper
• Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype.

  1998influential reference
• Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers.

  1997influential reference
• Human P450 metabolism of warfarin.

  1997cited by this paper
• Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic‐pharmacodynamic model

  1994influential reference
• Development and validation of a high-performance liquid chromatographic method for the quantitation of warfarin enantiomers in human plasma.

  1993cited by this paper

• Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo

  2024cites this paper
• Validation of R/S-Warfarin Analysis Method in Human Blood Plasma Using HPLC with Fluorescence Detection and its Application to Patient Samples

  2024cites this paper
• Review: Analisis Senyawa Obat Warfarin dalam Plasma Darah dengan Metode HPLC/KCKT

  2023cites this paper
• Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects.

  2023cites this paper
• An optoelectronic flow-through detectors for active ingredients determination in the pharmaceutical formulations.

  2021cites this paper
• Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD

  2020cites this paper
• Chiral voltammetric sensor for warfarin enantiomers based on carbon black paste electrode modified by 3,4,9,10-perylenetetracarboxylic acid

  2020cites this paper
• Simple and Fast Determination of Warfarin in Pharmaceutical Samples Using Boron‐Doped Diamond Electrode in BIA and FIA Systems with Multiple Pulse Amperometric Detection

  2017cites this paper